Is Neurosense Therapeutics Ltd (NRSN) Stock a Bad Value Friday?

The 29 rating InvestorsObserver gives to Neurosense Therapeutics Ltd (NRSN) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 71 percent of stocks in the Healthcare sector, NRSN’s 29 overall rating means the stock scores better than 29 of all stocks.

NRSN has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on NRSN!

See Full NRSN Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Neurosense Therapeutics Ltd Stock Today?

Neurosense Therapeutics Ltd (NRSN) stock has gained 1.08% while the S&P 500 is lower by -0.52% as of 10:15 AM on Friday, Mar 15. NRSN has gained $0.01 from the previous closing price of $1.39 on volume of 33,573 shares. Over the past year the S&P 500 is higher by 29.37% while NRSN is lower by -19.89%. NRSN lost -$0.86 per share the over the last 12 months. Click Here to get the full Stock Report for Neurosense Therapeutics Ltd stock.